0.05Open0.05Pre Close0 Volume743 Open Interest7.50Strike Price0.00Turnover356.46%IV131.60%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier7DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.0808Delta0.0912Gamma65.20Leverage Ratio-0.0158Theta0.0000Rho5.27Eff Leverage0.0007Vega
CureVac Stock Discussion
Benzinga· 1 min ago
New trial date for U.S. patent litigation set for March 3, 2025, following settlement with Acuitas Therapeutics.
First instance decision on validity of EP 3 708 668 B1 (split poly-A tail technology) scheduled for March 25, 2025, by European Patent Office in the context of the German patent liti...
loading...
No comment yet